Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-13

Clinical Trial Update: To Evaluate the Effect of MCS® in Prostate Cancer Prevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating MCS® for prostate cancer prevention; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MCS®

Snippet

Sponsor: Health Ever Bio-Tech Co., Ltd. | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING